Name:
COVID and Athletes
Description:
COVID and Athletes
Thumbnail URL:
https://cadmoremediastorage.blob.core.windows.net/6c1f546a-aa2c-40b0-b519-553fded5b8b0/thumbnails/6c1f546a-aa2c-40b0-b519-553fded5b8b0.jpeg?sv=2019-02-02&sr=c&sig=F%2FtjWxeEA64dQOAiQBO1wrf7Z48qUgeY7Rpzvgp86ao%3D&st=2024-12-21T13%3A15%3A05Z&se=2024-12-21T17%3A20%3A05Z&sp=r
Duration:
T00H04M12S
Embed URL:
https://stream.cadmore.media/player/6c1f546a-aa2c-40b0-b519-553fded5b8b0
Content URL:
https://cadmoreoriginalmedia.blob.core.windows.net/6c1f546a-aa2c-40b0-b519-553fded5b8b0/18778956.mp3?sv=2019-02-02&sr=c&sig=oX1evuD96tsus2Wq%2F02x2QF%2Ft5tF8zis0V8NTDBCzx0%3D&st=2024-12-21T13%3A15%3A05Z&se=2024-12-21T15%3A20%3A05Z&sp=r
Upload Date:
2022-02-28T00:00:00.0000000
Transcript:
Language: EN.
Segment:0 .
>> Practice Impact Extra podcasts are derived from Hurst's The Heart Board Review and other online resources available only through accesscardiology.com. >> It's August 2020, and the COVID-19 pandemic continues. It seems to affect against so many people who are healthy active individuals, as well as athletes. Hi, I'm Dr. Bernie, and welcome to the Practice Impact Extra.
COVID-19 is associated with significant mortality and morbidity, including adverse cardiovascular sequelae. Cardiologists in particular are charged with determining when competitive athletes and high active individuals who've been infected with COVID-19 and recovered are medically appropriate to return to play. The May 2020 JAMA Cardiology Guidelines developed by the ACC Sports and Exercise Cardiology Council with input from national leaders in sports cardiology provided expert consensus opinion of a clinical framework for the return to play in the era of COVID-19.
In fact, 22% of hospitalized patients have evidence of acute cardiac injury defined by elevated troponin and EKG abnormalities. That's 22% of COVID patient, and this has resulted in myocarditis by the virus that could lead to cardiac dysfunction, arrhythmias, and death. Could exercise in the acute phase result in an accelerated viral replication, increased inflammation, or even cellular necrosis?
The long-term clinical outcomes attributable to COVID-19 cardiac injury remain unknown. So, let me emphasize that the evidence-based recommendations for return to play guidelines are currently limited and clearly subjected to change as further data is obtained. I would direct you to review the COVID-19 Return to Play Algorithm for Competitive Athletes and Highly Active People. This was published online in JAMA Cardiology May 13, 2020.
This provides directed recommendation with temporal progression incorporating a time-based benchmark for COVID-19 and negative individuals who are asymptomatic. Also, guidelines for COVID-19 positive patients, including those who are asymptomatic, patients who are mildly symptomatic, but not hospitalized, and significantly symptomatic patients who have been hospitalized. Recommendations should be applied from the ACC and American Heart Association Athlete Myocardial Inflammation Myocarditis Guidelines.
My thought. There are imperfections, and the recommendations are exclusive just to cardiovascular disease, but the limitations from the pulmonary standpoint needed consideration as well. Guideline recommendations regarding intense exercise training and competition require very careful clinical consideration including duration and severity of COVID illness and post-infection serial cardiac evaluation based on extensive testing.
This viewpoint may also be helpful when evaluating a recreational athlete who is concerned about their COVID-19 exposure and whether they can return to usual recreational activity. I want to thank you for joining me, and see you next time on Practice Impact Extra. >> We hope you enjoyed this podcast from McGraw-Hill. Subscribers to AccessCardiology have instant access to over 25,000 pages of rich medical content, receive medical updates from trusted experts, and have access to other special features.
To subscribe or learn more, please visit accesscardiology.com.
